Pacira Biosciences, Stock Investor Sentiment
| PCRX Stock | USD 16.64 0.14 0.83% |
Slightly above 63% of Pacira BioSciences,'s investor base is looking to short. The analysis of overall sentiment of trading Pacira BioSciences, stock suggests that many investors are alarmed at this time. Pacira BioSciences,'s investing sentiment can be driven by a variety of factors including economic data, Pacira BioSciences,'s earnings reports, geopolitical events, and overall market trends.
Panic Vs Confidence
37
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Pacira BioSciences,'s input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Pacira BioSciences,.
News SentimentBullish | Hype SentimentBearish | Insider SentimentDisposing |
Pacira Historical Sentiment
Although Pacira BioSciences,'s investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Pacira, such as negative comments on social media and news outlets, may cause fear in the market and push Pacira BioSciences,'s investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Pacira.
Pacira |
Pacira BioSciences, Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Pacira BioSciences, can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Pacira BioSciences, Historical Investor Sentiment
Investor biases related to Pacira BioSciences,'s public news can be used to forecast risks associated with an investment in Pacira. The trend in average sentiment can be used to explain how an investor holding Pacira can time the market purely based on public headlines and social activities around Pacira BioSciences,. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Pacira BioSciences,'s market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Pacira BioSciences, and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Pacira BioSciences, news discussions. The higher the estimate score, the more favorable the investor's outlook on Pacira BioSciences,.
Far too much social signal, news, headlines, and media speculation about Pacira BioSciences, that are available to investors today. That information is available publicly through Pacira media outlets and privately through word of mouth or via Pacira internal channels. However, regardless of the origin, that massive amount of Pacira data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Pacira BioSciences, news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Pacira BioSciences, relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Pacira BioSciences,'s headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Pacira BioSciences, alpha.
Pacira BioSciences, Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Disposition of 5773 shares by Lauren Riker of Pacira Pharmaceuticals at 38.52 subject to Rule 16b-3 | 09/10/2024 |
2 | Disposition of 500 shares by Daryl Gaugler of Pacira BioSciences, at 12.86 subject to Rule 16b-3 | 09/13/2024 |
3 | Pacira wins Exparel Medicare J-code | 10/03/2024 |
4 | Disposition of 1066 shares by Pace Gary W of Pacira BioSciences, at 29.67 subject to Rule 16b-3 | 10/11/2024 |
5 | Acquisition by Brege Laura of 1000 shares of Pacira BioSciences, at 12.81 subject to Rule 16b-3 | 10/25/2024 |
6 | Analysts Estimate Moderna to Report a Decline in Earnings What to Look Out for | 10/31/2024 |
7 | Acquisition by Shawn Cross of 75000 shares of Pacira BioSciences, subject to Rule 16b-3 | 11/01/2024 |
8 | Acquisition by Shawn Cross of 200000 shares of Pacira BioSciences, at 16.45 subject to Rule 16b-3 | 11/04/2024 |
9 | Pacira BioSciences Inc Q3 2024 Everything You Need To Know Ahead Of Earnings | 11/05/2024 |
10 | Pacira Q3 Earnings Snapshot | 11/06/2024 |
11 | Pacira BioSciences Inc Q3 2024 Earnings Call Highlights Strong Financial Position ... | 11/07/2024 |
12 | Pacira BioSciences Buy Rating Reiterated at Needham Company LLC | 11/11/2024 |
13 | Pacira BioSciences SWOT analysis stock faces patent challenges amid growth initiatives | 11/13/2024 |
14 | Pacira BioSciences, Inc. Shares Sold by Global Alpha Capital Management Ltd. - MarketBeat | 11/20/2024 |
15 | Pacira BioSciences Inc Shares Gap Down to 16.49 on Nov 26 | 11/26/2024 |
Additional Tools for Pacira Stock Analysis
When running Pacira BioSciences,'s price analysis, check to measure Pacira BioSciences,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pacira BioSciences, is operating at the current time. Most of Pacira BioSciences,'s value examination focuses on studying past and present price action to predict the probability of Pacira BioSciences,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pacira BioSciences,'s price. Additionally, you may evaluate how the addition of Pacira BioSciences, to your portfolios can decrease your overall portfolio volatility.